期刊文献+

脂蛋白相关性磷脂酶A2和巨噬细胞迁移抑制因子与易损斑块相关性的iMap-血管内超声研究 被引量:6

An iMap-IVUS study for the correlation of Lp-PLA2 and MIF and vulnerabl plaques
原文传递
导出
摘要 目的:通过iMap-血管内超声(iMap-IVUS)分析冠心病患者动脉粥样硬化斑块成分,探讨脂蛋白相关性磷脂酶A2(Lp-PLA2)及巨噬细胞迁移抑制因子(MIF)水平与易损斑块间的关系。方法:连续选取冠心病患者74例,对其3支冠状动脉(冠脉)均进行IVUS检查,通过IVUS后处理软件测量患者冠脉管腔面积、斑块成分等相关指标,并根据患者病变性质将其分为斑块破裂组、易损斑块组和无易损斑块组,分析Lp-PLA2及MIF水平与患者易损斑块间的关系。结果:斑块破裂组较非斑块破裂组病变长度更长(P<0.001),有更大的外弹力膜面积(P=0.014)和斑块面积(P=0.008),含有更多的脂质成分(P=0.009)和坏死核心(P<0.001)。易损斑块组较无易损斑块组患者有更多的脂质成分(P<0.05)和坏死核心(P<0.001)。斑块破裂组Lp-PLA2水平明显高于非斑块破裂组(P=0.001),MIF水平差异无统计学意义;与无易损斑块组相比,易损斑块组Lp-PLA2水平显著升高(P=0.001),MIF水平未见统计学差异。Lp-PLA2与斑块易损性呈中等相关(r=0.448,P<0.01),MIF与斑块易损性无明显相关性(r=0.121,P>0.05)。结论:经iMAP-IVUS证实,Lp-PLA2能够反映斑块的易损性,MIF不能作为易损斑块的预测因子。 Objective.. To investigate relationships among lipoprotein associated phospholipase A2 (Lp-PLA2) and macrophage migration inhibitory factor (MIF) and vulnerable plaques by analysis of atheroselerotie plaque components using iMap-intravascular ultrasound(IVUS). Method: Seventy-four patients with coronary heart dis- ease were included. Patients's three vessels were performed on iMap-IVUS. The relationships among Lp-PLA2, MIF levels and vulnerable plaques measured using IVUS post-processing software. Result:Ruptured plaque group had longer lesion length (P〈0.001 ) , greater external elastic membrane area (P = 0.014) and plaque area ( P = 0. 008), containing more lipid composition (P=0. 009) and necrotic core (P〈0. 001) than the group without rup- tured plaque. The vulnerable plaque group had more lipid composition (P〈0.05) and necrotic core (P〈0. 001) than the group without vulnerable plaque group. Ruptured plaque group's Lp-PLA2 level was significantly higher than that in the group without plaque ruptured (P=0. 001), while levels of MIF had no statistical difference (P〈 0.05); Compared with the group without vulnerable plaque, the level of Lp-PLA2 increased significantly (P= 0. 001) in the vulnerable plaque group. The level of MIF had no statistical difference between two groups. Lp- PLA2 level was moderately correlated to the vulnerable plaque (r= 0. 448, P〈0.01), while MIF level had no significant correlation with the vulnerable plaque (r=0. 121, P〉0.05). Conclusion: Confirmed by the iMAP-IVUS, Lp-PLA2 could reflect the vulnerability of the plaques, but MIF can not as a predictor of vulnerable plaques.
机构地区 天津市胸科医院
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2015年第5期560-563,共4页 Journal of Clinical Cardiology
基金 天津市卫生局课题(No:2010KZ63) 天津市卫生计生委科技基金(No:14KG126)
关键词 脂蛋白相关性磷脂酶A2 巨噬细胞迁移抑制因子 易损斑块 iMap-血管内超声 lipoprotein associated phospholipase A2 macrophage migration inhibitory factor vulnerable plaques iMap - intravascular ultrasound
  • 相关文献

参考文献6

  • 1TRUSINSKIS K, JUHNEVICA D, STRENGE K, et al. iMap intravascular ultrasound evaluation of culprit and non-culprit lesions in patients with ST-elevation myocardial infarction [J]. Cardiovasc Revasc Med, 2013,14:71--75. 被引量:1
  • 2RIDKER P M, MACFADYEN J G, WOLFERT R L, et al. Relationship of lipoprotein-associated phos- pholipase A(2) mass and activity with incident vascu- lar events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial [J]. Clin Chem, 2012,58:877--886. 被引量:1
  • 3WHITE H D, SIMES J, STEWART R A, et al. Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study [J]. J Am Heart Assoc, 2013, 2: e000360. 被引量:1
  • 4SERRUYS P W, GARCIA - GARCIA H M, BUSZ- MAN P, et al. Effects of the direct lipoprotein - as- sociated phospholipase A (2) inhibitor darapladib on human coronary atherosclerotic plaque [J]. Circula- tion, 2008,118:1172-1182. 被引量:1
  • 5KONG Y Z, HUANG X R, OUYANG X, et al. Evi- dence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques [J]. Cardiovasc Res, 2005,65:272--282. 被引量:1
  • 6HEDER C, LLLIG T,BAUMERT J, et al. Macrophage migration inhibitory factor(MIF)and risk for corenary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984 -- 2002 [J]. Ath- eresclerosis, 2008,200:380 -- 388. 被引量:1

同被引文献79

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部